744 related articles for article (PubMed ID: 25466406)
1. Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale.
Martínez-Martín P; Rodríguez-Blázquez C; Mario Alvarez ; Arakaki T; Arillo VC; Chaná P; Fernández W; Garretto N; Martínez-Castrillo JC; Rodríguez-Violante M; Serrano-Dueñas M; Ballesteros D; Rojo-Abuin JM; Chaudhuri KR; Merello M
Parkinsonism Relat Disord; 2015 Jan; 21(1):50-4. PubMed ID: 25466406
[TBL] [Abstract][Full Text] [Related]
2. The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease.
Rodriguez-Blazquez C; Rojo-Abuin JM; Alvarez-Sanchez M; Arakaki T; Bergareche-Yarza A; Chade A; Garretto N; Gershanik O; Kurtis MM; Martinez-Castrillo JC; Mendoza-Rodriguez A; Moore HP; Rodriguez-Violante M; Singer C; Tilley BC; Huang J; Stebbins GT; Goetz CG; Martinez-Martin P
Parkinsonism Relat Disord; 2013 Oct; 19(10):889-93. PubMed ID: 23791519
[TBL] [Abstract][Full Text] [Related]
3. Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale.
Martinez-Martin P; Chaudhuri KR; Rojo-Abuin JM; Rodriguez-Blazquez C; Alvarez-Sanchez M; Arakaki T; Bergareche-Yarza A; Chade A; Garretto N; Gershanik O; Kurtis MM; Martinez-Castrillo JC; Mendoza-Rodriguez A; Moore HP; Rodriguez-Violante M; Singer C; Tilley BC; Huang J; Stebbins GT; Goetz CG
Eur J Neurol; 2015 Jan; 22(1):37-43. PubMed ID: 23607783
[TBL] [Abstract][Full Text] [Related]
4. The clinically important difference on the unified Parkinson's disease rating scale.
Shulman LM; Gruber-Baldini AL; Anderson KE; Fishman PS; Reich SG; Weiner WJ
Arch Neurol; 2010 Jan; 67(1):64-70. PubMed ID: 20065131
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients.
Martínez-Martín P; Rodríguez-Blázquez C; Forjaz MJ; Alvarez-Sánchez M; Arakaki T; Bergareche-Yarza A; Chade A; Garretto N; Gershanik O; Kurtis MM; Martínez-Castrillo JC; Mendoza-Rodríguez A; Moore HP; Rodríguez-Violante M; Singer C; Tilley BC; Huang J; Stebbins GT; Goetz CG
Eur J Neurol; 2014 Mar; 21(3):519-24. PubMed ID: 24447695
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the non-motor items of the MDS-UPDRS and Quality of Life in patients with Parkinson's disease.
Skorvanek M; Rosenberger J; Minar M; Grofik M; Han V; Groothoff JW; Valkovic P; Gdovinova Z; van Dijk JP
J Neurol Sci; 2015; 353(1-2):87-91. PubMed ID: 25918077
[TBL] [Abstract][Full Text] [Related]
7. Correlation between the Movement Disorders Society Unified Parkinson's Disease rating scale (MDS-UPDRS) and the Unified Parkinson's Disease rating scale (UPDRS) during L-dopa acute challenge.
Merello M; Gerschcovich ER; Ballesteros D; Cerquetti D
Parkinsonism Relat Disord; 2011 Nov; 17(9):705-7. PubMed ID: 21784692
[TBL] [Abstract][Full Text] [Related]
8. SPES/SCOPA and MDS-UPDRS: formulas for converting scores of two motor scales in Parkinson's disease.
Verbaan D; van Rooden SM; Benit CP; van Zwet EW; Marinus J; van Hilten JJ
Parkinsonism Relat Disord; 2011 Sep; 17(8):632-4. PubMed ID: 21696993
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive grading of Parkinson's disease using motor and non-motor assessments: addressing a key unmet need.
Martinez-Martin P; Ray Chaudhuri K
Expert Rev Neurother; 2018 Jan; 18(1):41-50. PubMed ID: 29090594
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal metric properties of disability rating scales for Parkinson's disease.
Martinez-Martin P; Prieto L; Forjaz MJ
Value Health; 2006; 9(6):386-93. PubMed ID: 17076869
[TBL] [Abstract][Full Text] [Related]
11. Simplified conversion method for unified Parkinson's disease rating scale motor examinations.
Hentz JG; Mehta SH; Shill HA; Driver-Dunckley E; Beach TG; Adler CH
Mov Disord; 2015 Dec; 30(14):1967-70. PubMed ID: 26779608
[TBL] [Abstract][Full Text] [Related]
12. Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease.
Gallagher DA; Goetz CG; Stebbins G; Lees AJ; Schrag A
Mov Disord; 2012 Jan; 27(1):79-83. PubMed ID: 21915909
[TBL] [Abstract][Full Text] [Related]
13. The association between Parkinson's disease symptom side-of-onset and performance on the MDS-UPDRS scale part IV: Motor complications.
Bay AA; Hart AR; Michael Caudle W; Corcos DM; Hackney ME
J Neurol Sci; 2019 Jan; 396():262-265. PubMed ID: 30537631
[TBL] [Abstract][Full Text] [Related]
14. Unified Parkinson's disease rating scale motor examination: are ratings of nurses, residents in neurology, and movement disorders specialists interchangeable?
Post B; Merkus MP; de Bie RM; de Haan RJ; Speelman JD
Mov Disord; 2005 Dec; 20(12):1577-84. PubMed ID: 16116612
[TBL] [Abstract][Full Text] [Related]
15. Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS).
Martinez-Martin P; Rodriguez-Blazquez C; Alvarez-Sanchez M; Arakaki T; Bergareche-Yarza A; Chade A; Garretto N; Gershanik O; Kurtis MM; Martinez-Castrillo JC; Mendoza-Rodriguez A; Moore HP; Rodriguez-Violante M; Singer C; Tilley BC; Huang J; Stebbins GT; Goetz CG
J Neurol; 2013 Jan; 260(1):228-36. PubMed ID: 22865238
[TBL] [Abstract][Full Text] [Related]
16. The SCOPA-Motor Scale for assessment of Parkinson's disease is a consistent and valid measure.
Martínez-Martín P; Benito-León J; Burguera JA; Castro A; Linazasoro G; Martínez-Castrillo JC; Valldeoriola F; Vázquez A; Vivancos F; del Val J; van Blercom N; Frades B
J Clin Epidemiol; 2005 Jul; 58(7):674-9. PubMed ID: 15939218
[TBL] [Abstract][Full Text] [Related]
17. Minimal clinically important difference on the Motor Examination part of MDS-UPDRS.
Horváth K; Aschermann Z; Ács P; Deli G; Janszky J; Komoly S; Balázs É; Takács K; Karádi K; Kovács N
Parkinsonism Relat Disord; 2015 Dec; 21(12):1421-6. PubMed ID: 26578041
[TBL] [Abstract][Full Text] [Related]
18. Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments.
Lang AE; Eberly S; Goetz CG; Stebbins G; Oakes D; Marek K; Ravina B; Tanner CM; Shoulson I;
Mov Disord; 2013 Dec; 28(14):1980-6. PubMed ID: 24123383
[TBL] [Abstract][Full Text] [Related]
19. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Rotigotine at Different Stages of Parkinson's Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage.
Giladi N; Nicholas AP; Asgharnejad M; Dohin E; Woltering F; Bauer L; Poewe W
J Parkinsons Dis; 2016 Oct; 6(4):741-749. PubMed ID: 27567886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
